REQUEST A DEMO
Total
USD $0.00
Search more companies

Opal Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Opal Pharmaceuticals Pvt Ltd Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Opal Pharmaceuticals Pvt Ltd is an unlisted company, incorporated on 23/03/1983. It has its registered office in the State of Rajasthan, India. Company's corporate identification number (CIN) is U24232RJ1983PTC002681 and registration number is 002681. The company is a trade company, it is engaged in wholesale trading.

Legal Address
D-50, Hathi Babu Marg, Banipark,
Jaipur; Rajasthan; Postal Code: 302016

Contact Details: Purchase the Opal Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Opal Pharmaceuticals Pvt Ltd report to view the information.
Registered Capital:
Purchase the Opal Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
March 23, 1983
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
60.65%
Purchase this report to view the information.
28.16%
Purchase this report to view the information.
11.19%
Company Performance
Financial values in the chart are available after Opal Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
1.6%
Total operating revenue
2.47%
Operating profit (EBIT)
-31.17%
EBITDA
-1.79%
Net Profit (Loss) for the Period
-85.51%
Total assets
19.58%
Total equity
0.8%
Operating Profit Margin (ROS)
-0.05%
Net Profit Margin
-0.22%
Return on Equity (ROE)
-4.7%
Debt to Equity Ratio
72.31%
Quick Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?